Demonstration	O
of	O
a	O
1	B-protein
,	I-protein
25-dihydroxyvitamin	I-protein
D3-responsive	I-protein
protein	I-protein
in	O
human	B-cell_type
lymphocytes	I-cell_type
:	O
immunologic	O
crossreactivity	O
and	O
inverse	O
regulation	O
with	O
the	O
vitamin	B-protein
D	I-protein
receptor	I-protein
.	O

Using	O
Western	O
blot	O
analysis	O
with	O
a	O
monoclonal	B-protein
antibody	I-protein
recognizing	O
a	O
17-amino	B-protein
acid	I-protein
epitope	I-protein
of	O
the	O
1	B-protein
,	I-protein
25-dihydroxyvitamin	I-protein
D3	I-protein
[	I-protein
1	I-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
]	I-protein
receptor	I-protein
,	O
we	O
have	O
detected	O
two	O
crossreacting	B-protein
proteins	I-protein
in	O
activated	B-cell_type
normal	I-cell_type
human	I-cell_type
lymphocytes	I-cell_type
.	O

The	O
smaller	O
of	O
the	O
two	O
proteins	O
(	O
50	B-protein
kDa	I-protein
)	O
was	O
indistinguishable	O
from	O
the	O
classical	O
1	B-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
receptor	I-protein
and	O
,	O
similar	O
to	O
the	O
classical	O
1	B-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
receptor	I-protein
,	O
was	O
upregulated	O
in	O
a	O
dose-dependent	O
fashion	O
by	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
.	O

The	O
larger	O
crossreacting	O
protein	O
exhibited	O
an	O
electrophoretic	O
mobility	O
of	O
80	O
kDa	O
,	O
was	O
localized	O
in	O
the	O
cell	O
cytosol	O
,	O
and	O
appeared	O
to	O
be	O
specific	O
for	O
activated	B-cell_type
lymphocytes	I-cell_type
since	O
it	O
was	O
not	O
detected	O
in	O
several	O
other	O
human	B-cell_type
cells	I-cell_type
including	O
monocytes	B-cell_type
.	O

More	O
strikingly	O
,	O
the	O
80-kDa	B-protein
protein	I-protein
was	O
downregulated	O
in	O
a	O
dose-dependent	O
fashion	O
by	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
;	O
this	O
effect	O
was	O
independent	O
of	O
the	O
mode	O
of	O
lymphocyte	O
activation	O
and	O
specific	O
for	O
the	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
metabolite	O
of	O
vitamin	O
D3	O
.	O

However	O
,	O
two	O
potent	O
immunosuppressive	O
agents	O
,	O
glucocorticoids	O
and	O
cyclosporin	O
A	O
,	O
also	O
inhibited	O
the	O
80-kDa	B-protein
protein	I-protein
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

88	NULL
,	NULL
pp	NULL
.	NULL

8347-8351	NULL
,	NULL
October	NULL
1991	NULL
Immunology	NULL
Demonstration	NULL
of	NULL
a	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
-responsive	NULL
protein	NULL
in	NULL
human	NULL
lymphocytes	NULL
:	NULL
Immunologic	NULL
crossreactivity	NULL
and	NULL
inverse	NULL
regulation	NULL
with	NULL
the	NULL
vitamin	NULL
D	NULL
receptor	NULL
(	NULL
lymphocyte	NULL
activation	NULL
/	NULL
glucocorticoids	NULL
/cyclosporin	NULL
A	NULL
)	NULL
X1ao-PENG	NULL
Yu	NULL
,	NULL
Frank	NULL
G.	NULL
HustmyER®	NULL
,	NULL
W.	NULL
TimotHyYy	NULL
GARVEY	NULL
,	NULL
anD	NULL
Stavros	NULL
C.	NULL
ManoLaGas*	NULL
Section	NULL
of	NULL
Endocrinology	NULL
and	NULL
Metabolism	NULL
,	NULL
Veterans	NULL
Administration	NULL
Medical	NULL
Center	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Indiana	NULL
University	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
46202	NULL
Communicated	NULL
by	NULL
Robert	NULL
H.	NULL
Wasserman	NULL
,	NULL
June	NULL
11	NULL
,	NULL
1991	NULL
ABSTRACT	NULL
Using	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
recognizing	NULL
a	NULL
17-amino	NULL
acid	NULL
epitope	NULL
of	NULL
the	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
[	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
]	NULL
receptor	NULL
,	NULL
we	NULL
have	NULL
detected	NULL
two	NULL
crossreacting	NULL
proteins	NULL
in	NULL
activated	NULL
normal	NULL
human	NULL
lymphocytes	NULL
.	NULL

The	NULL
smaller	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
(	NULL
50	NULL
kDa	NULL
)	NULL
was	NULL
indistinguishable	NULL
from	NULL
the	NULL
classical	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
and	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
classical	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
,	NULL
was	NULL
upregulated	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

The	NULL
larger	NULL
crossreacting	NULL
protein	NULL
exhibited	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
80	NULL
kDa	NULL
,	NULL
was	NULL
localized	NULL
in	NULL
the	NULL
cell	NULL
cytosol	NULL
,	NULL
and	NULL
appeared	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
activated	NULL
lymphocytes	NULL
since	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
several	NULL
other	NULL
human	NULL
cells	NULL
including	NULL
monocytes	NULL
.	NULL

More	NULL
strikingly	NULL
,	NULL
the	NULL
80-kDa	NULL
protein	NULL
was	NULL
downregulated	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
;	NULL
this	NULL
effect	NULL
was	NULL
independent	NULL
of	NULL
the	NULL
mode	NULL
of	NULL
lymphocyte	NULL
activation	NULL
and	NULL
specific	NULL
for	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
me-tabolite	NULL
of	NULL
vitamin	NULL
D	NULL
;	NULL
.	NULL

However	NULL
,	NULL
two	NULL
potent	NULL
immunosuppressive	NULL
agents	NULL
,	NULL
glucocorticoids	NULL
and	NULL
cyclosporin	NULL
A	NULL
,	NULL
also	NULL
inhibited	NULL
the	NULL
80-kDa	NULL
protein	NULL
.	NULL

Evidence	NULL
obtained	NULL
during	NULL
the	NULL
last	NULL
few	NULL
years	NULL
has	NULL
revealed	NULL
that	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
{	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
]	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
playing	NULL
a	NULL
major	NULL
role	NULL
in	NULL
mineral	NULL
and	NULL
skeletal	NULL
homeostasis	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
immune	NULL
phenomena	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
monocytes/macrophages	NULL
and	NULL
lymphocytes	NULL
express	NULL
vitamin	NULL
D	NULL
;	NULL
receptors	NULL
(	NULL
VDRs	NULL
)	NULL
.	NULL

In	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
the	NULL
receptor	NULL
protein	NULL
is	NULL
expressed	NULL
constitutively	NULL
.	NULL

In	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
,	NULL
however	NULL
,	NULL
the	NULL
receptor	NULL
protein	NULL
is	NULL
expressed	NULL
only	NULL
after	NULL
activation	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
receptors	NULL
,	NULL
a	NULL
series	NULL
of	NULL
hormonal	NULL
effects	NULL
on	NULL
immune	NULL
phenomena	NULL
have	NULL
been	NULL
de-scribed	NULL
.	NULL

Thus	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
causes	NULL
changes	NULL
in	NULL
the	NULL
proliferative	NULL
response	NULL
of	NULL
activated	NULL
lymphocytes	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
by	NULL
preventing	NULL
the	NULL
cells	NULL
from	NULL
progressing	NULL
from	NULL
the	NULL
early	NULL
to	NULL
late	NULL
G	NULL
;	NULL
phase	NULL
border	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
6	NULL
)	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
can	NULL
also	NULL
influence	NULL
the	NULL
production	NULL
of	NULL
monocyte-derived	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
in-terleukins	NULL
1	NULL
and	NULL
6	NULL
(	NULL
ref	NULL
.	NULL

7	NULL
and	NULL
F.G.H	NULL
.	NULL

,	NULL
G.	NULL
Girasole	NULL
,	NULL
and	NULL
S	NULL
$	NULL
.C.M	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
decreases	NULL
the	NULL
production	NULL
of	NULL
the	NULL
granulocyte/macrophage	NULL
col-ony-stimulating	NULL
factor	NULL
and	NULL
interferon	NULL
y	NULL
in	NULL
lectin-stimulated	NULL
lymphocytes	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
inhibits	NULL
immuno-globulin	NULL
production	NULL
in	NULL
B	NULL
lymphocytes	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
and	NULL
may	NULL
influence	NULL
thymocyte	NULL
maturation	NULL
and	NULL
intrathymic	NULL
differentiation	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
serendipitous	NULL
discovery	NULL
of	NULL
an	NULL
80-kDa	NULL
protein	NULL
in	NULL
activated	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
that	NULL
is	NULL
responsive	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

This	NULL
80-kDa	NULL
protein	NULL
shares	NULL
immunologic	NULL
crossreactivity	NULL
with	NULL
the	NULL
VDR	NULL
but	NULL
is	NULL
downregulated	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
VDR	NULL
,	NULL
which	NULL
is	NULL
upregulated	NULL
by	NULL
its	NULL
own	NULL
ligand	NULL
.	NULL

The	NULL
influence	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
this	NULL
80-kDa	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

8347	NULL
protein	NULL
is	NULL
independent	NULL
of	NULL
the	NULL
mode	NULL
of	NULL
lymphocyte	NULL
activation	NULL
and	NULL
is	NULL
shared	NULL
by	NULL
two	NULL
immunosuppressive	NULL
agents	NULL
,	NULL
glucocorticoids	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials	NULL
.	NULL

Radioiodinated	NULL
protein	NULL
A	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
30	NULL
mCi/mg	NULL
;	NULL
1	NULL
Ci	NULL
=	NULL
37	NULL
GBq	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Amersham	NULL
.	NULL

Crystalline	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
24,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
and	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
were	NULL
generous	NULL
gifts	NULL
from	NULL
Milan	NULL
Uskokovic	NULL
(	NULL
Hoffmann-LaRoche	NULL
)	NULL
.	NULL

Phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
,	NULL
triamcinolone	NULL
acetonide	NULL
,	NULL
lipopolysac-charide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
at	NULL
pH	NULL
7.4	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
affinity-isolated	NULL
rabbit	NULL
anti-rat	NULL
IgG	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Cyclosporin	NULL
A	NULL
was	NULL
donated	NULL
by	NULL
Sandoz	NULL
(	NULL
East	NULL
Ha-nover	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
was	NULL
prepared	NULL
as	NULL
a	NULL
stock	NULL
solution	NULL
at	NULL
1	NULL
mg/ml	NULL
in	NULL
ethanol/RPMI	NULL
1640	NULL
medium	NULL
,	NULL
1:9	NULL
(	NULL
vol/vol	NULL
)	NULL
.	NULL

Fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
HyClone	NULL
.	NULL

Antibiotics	NULL
and	NULL
L-glutamine	NULL
were	NULL
obtained	NULL
from	NULL
Irvine	NULL
Scientific	NULL
.	NULL

Acryla-mide	NULL
,	NULL
SDS	NULL
,	NULL
and	NULL
N	NULL
,	NULL
N'-methylenebisacrylamide	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
Bio-Rad	NULL
.	NULL

The	NULL
OKT3	NULL
monoclonal	NULL
antibody	NULL
to	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
was	NULL
generated	NULL
from	NULL
hybridoma	NULL
cells	NULL
and	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:250	NULL
.	NULL

The	NULL
anti-VDR	NULL
monoclonal	NULL
antibody	NULL
9A77	NULL
(	NULL
12	NULL
)	NULL
and	NULL
an	NULL
enriched	NULL
preparation	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
VDR	NULL
from	NULL
transfected	NULL
COS	NULL
cells	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
J.	NULL
Wesley	NULL
Pike	NULL
(	NULL
Baylor	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

Cells	NULL
and	NULL
Culture	NULL
Conditions	NULL
.	NULL

Blood	NULL
was	NULL
obtained	NULL
from	NULL
normal	NULL
volunteers	NULL
from	NULL
either	NULL
sex	NULL
or	NULL
from	NULL
buffy	NULL
coats	NULL
in	NULL
protocols	NULL
approved	NULL
by	NULL
the	NULL
Indiana	NULL
University	NULL
Institutional	NULL
Review	NULL
Board	NULL
,	NULL
and	NULL
the	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMCs	NULL
)	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll/Paque	NULL
gradient	NULL
centrifuga-tion	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
resuspended	NULL
at	NULL
1-2	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
heat-inactivated	NULL
FBS	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
antibiotics	NULL
(	NULL
streptomycin	NULL
at	NULL
100	NULL
ug/ml	NULL
and	NULL
penicillin	NULL
at	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
and	NULL
25	NULL
mM	NULL
Hepes	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
plastic	NULL
culture	NULL
flasks	NULL
for	NULL
72	NULL
hr	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
/95	NULL
%	NULL
air	NULL
and	NULL
stimulated	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/mi	NULL
)	NULL
,	NULL
with	NULL
OKT3	NULL
(	NULL
1:250	NULL
dilution	NULL
)	NULL
,	NULL
or	NULL
with	NULL
other	NULL
reagents	NULL
as	NULL
indicated	NULL
.	NULL

For	NULL
the	NULL
cell-type	NULL
specificity	NULL
experiments	NULL
,	NULL
PBMCs	NULL
were	NULL
incubated	NULL
in	NULL
plastic	NULL
culture	NULL
dishes	NULL
(	NULL
100	NULL
mm	NULL
)	NULL
at	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
cm	NULL
'	NULL
of	NULL
growth	NULL
area	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

The	NULL
nonadherent	NULL
cells	NULL
were	NULL
then	NULL
aspirated	NULL
.	NULL

The	NULL
adherent	NULL
cells	NULL
were	NULL
scraped	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
2	NULL
%	NULL
FBS	NULL
.	NULL

The	NULL
enriched	NULL
monocytes	NULL
were	NULL
heat-shocked	NULL
at	NULL
45°C	NULL
for	NULL
20	NULL
min	NULL
and	NULL
then	NULL
allowed	NULL
Abbreviations	NULL
:	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
;	NULL
VDR	NULL
,	NULL
vita-	NULL
min	NULL
D	NULL
;	NULL
receptor	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccha-	NULL
ride	NULL
;	NULL
PBMC	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cell	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
;	NULL
BSA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Veterans	NULL
Administration	NULL
Medical	NULL
Center	NULL
,	NULL
Section	NULL
of	NULL
Endocrinology/Metabo-lism	NULL
(	NULL
111E	NULL
)	NULL
,	NULL
1481	NULL
West	NULL
10th	NULL
Street	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
46202	NULL
.	NULL

8348	NULL
Immunology	NULL
:	NULL
Yu	NULL
et	NULL
al	NULL
.	NULL

to	NULL
recover	NULL
at	NULL
37°C	NULL
for	NULL
6	NULL
hr	NULL
.	NULL

Cell	NULL
viability	NULL
(	NULL
96	NULL
%	NULL
)	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
after	NULL
heat	NULL
shock	NULL
.	NULL

An	NULL
enriched	NULL
monocyte	NULL
preparation	NULL
obtained	NULL
by	NULL
Percoll	NULL
gradient	NULL
separation	NULL
from	NULL
PBMCs	NULL
was	NULL
also	NULL
stimulated	NULL
for	NULL
72	NULL
hr	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

The	NULL
human	NULL
promyelocytic	NULL
leukemic	NULL
cell	NULL
line	NULL
HL-60	NULL
was	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
and	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
heat-inactivated	NULL
FBS	NULL
.	NULL

The	NULL
osteoblastic	NULL
human	NULL
osteosarcoma	NULL
cell	NULL
line	NULL
SAOS-2	NULL
was	NULL
maintained	NULL
in	NULL
McCoy	NULL
's	NULL
5A	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

Cytosol	NULL
Preparations	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
at	NULL
pH	NULL
7.4	NULL
and	NULL
counted	NULL
.	NULL

Washed	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
KETD-O.3	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4/1.5	NULL
mM	NULL
EDTA/5	NULL
mM	NULL
dithiothreitol/1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride/0.3	NULL
M	NULL
KCI	NULL
)	NULL
and	NULL
sonicated	NULL
with	NULL
three	NULL
20-sec	NULL
cycles	NULL
interrupted	NULL
by	NULL
60-sec	NULL
pauses	NULL
(	NULL
Sonifer	NULL
cell	NULL
disrupter	NULL
,	NULL
Heat	NULL
Systems/	NULL
Ultrasonics	NULL
,	NULL
Farmingdale	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
sonicate	NULL
was	NULL
centrifuged	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
105,000	NULL
x	NULL
g	NULL
in	NULL
a	NULL
L8-55	NULL
Beckman	NULL
ultracen-trifuge	NULL
to	NULL
yield	NULL
a	NULL
supernatant	NULL
(	NULL
cytosol	NULL
)	NULL
fraction	NULL
.	NULL

Human	NULL
kidneys	NULL
and	NULL
brain	NULL
cortex	NULL
were	NULL
obtained	NULL
from	NULL
cadavers	NULL
and	NULL
washed	NULL
thoroughly	NULL
with	NULL
PBS	NULL
at	NULL
pH	NULL
7.4	NULL
.	NULL

The	NULL
kidney	NULL
cortex	NULL
was	NULL
separated	NULL
from	NULL
medulla	NULL
and	NULL
minced	NULL
.	NULL

Cytosol	NULL
of	NULL
these	NULL
tissues	NULL
was	NULL
prepared	NULL
by	NULL
homogenization	NULL
in	NULL
KETD-O0.3	NULL
with	NULL
a	NULL
Polytron	NULL
(	NULL
Brinkmann	NULL
)	NULL
and	NULL
briefly	NULL
centrifuged	NULL
at	NULL
1000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
then	NULL
the	NULL
supernatants	NULL
were	NULL
ultracentrifuged	NULL
at	NULL
105,000	NULL
x	NULL
g	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

All	NULL
procedures	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
cytosol	NULL
fraction	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
4°C	NULL
or	NULL
on	NULL
ice	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
modified	NULL
method	NULL
of	NULL
Lowry	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Subcellular	NULL
Fractions	NULL
.	NULL

After	NULL
incubation	NULL
and	NULL
washes	NULL
,	NULL
PHA-activated	NULL
PBMCs	NULL
were	NULL
disrupted	NULL
by	NULL
hypotonic	NULL
lysis	NULL
and	NULL
homogenization	NULL
,	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
suspension	NULL
of	NULL
broken	NULL
cells	NULL
was	NULL
centrifuged	NULL
for	NULL
15	NULL
min	NULL
at	NULL
1500	NULL
x	NULL
g	NULL
to	NULL
separate	NULL
the	NULL
nuclear	NULL
fraction	NULL
from	NULL
the	NULL
supernatants	NULL
.	NULL

The	NULL
resultant	NULL
supernatant	NULL
was	NULL
gently	NULL
aspirated	NULL
and	NULL
then	NULL
centrifuged	NULL
for	NULL
60	NULL
min	NULL
at	NULL
105,000	NULL
x	NULL
g	NULL
to	NULL
separate	NULL
the	NULL
cytosolic	NULL
fraction	NULL
from	NULL
the	NULL
cell	NULL
membranes	NULL
.	NULL

Nuclei	NULL
and	NULL
membranes	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
IPB	NULL
buffer	NULL
(	NULL
0.01	NULL
M	NULL
TrissHCl	NULL
,	NULL
pH	NULL
7.5/1	NULL
mM	NULL
EDTA/0.5	NULL
mM	NULL
EGTA/O.15	NULL
mM	NULL
spermine/0.5	NULL
mM	NULL
spermidine/5	NULL
mM	NULL
dithiothreitol/0.32	NULL
M	NULL
sucrose	NULL
)	NULL
,	NULL
resuspended	NULL
in	NULL
0.3	NULL
ml	NULL
of	NULL
KETD-O0.3	NULL
,	NULL
and	NULL
sonicated	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

Crude	NULL
cytosols	NULL
or	NULL
enriched	NULL
preparations	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
VDR	NULL
were	NULL
electrophoresed	NULL
on	NULL
SDS/polyacrylamide	NULL
gels	NULL
(	NULL
7.5	NULL
%	NULL
or	NULL
10	NULL
%	NULL
polyacrylamide	NULL
)	NULL
as	NULL
described	NULL
by	NULL
Laemmli	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
then	NULL
electro-phoretically	NULL
transferred	NULL
from	NULL
the	NULL
gel	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
by	NULL
using	NULL
a	NULL
TE42	NULL
Transphor	NULL
apparatus	NULL
(	NULL
Hoefer	NULL
)	NULL
and	NULL
50	NULL
mM	NULL
sodium	NULL
phosphate	NULL
transfer	NULL
buffer	NULL
cooled	NULL
by	NULL
a	NULL
recircu-lator	NULL
(	NULL
RMG	NULL
Lauda	NULL
,	NULL
Brinkmann	NULL
)	NULL
.	NULL

Complete	NULL
transfer	NULL
of	NULL
all	NULL
proteins	NULL
was	NULL
achieved	NULL
by	NULL
3.5	NULL
hr	NULL
at	NULL
20	NULL
V	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
any	NULL
staining	NULL
in	NULL
the	NULL
50-	NULL
to	NULL
80-kDa	NULL
range	NULL
of	NULL
the	NULL
gels	NULL
by	NULL
Coomassie	NULL
blue	NULL
.	NULL

Upon	NULL
completion	NULL
of	NULL
the	NULL
transfer	NULL
,	NULL
the	NULL
nitrocellulose	NULL
membranes	NULL
were	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
as	NULL
follows	NULL
:	NULL
Membranes	NULL
were	NULL
incubated	NULL
with	NULL
PBS	NULL
at	NULL
pH	NULL
7.2	NULL
(	NULL
0.02	NULL
M	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
pH	NULL
7.2/0.15	NULL
M	NULL
NaCl	NULL
)	NULL
containing	NULL
3	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
,	NULL
for	NULL
2-4	NULL
hr	NULL
at	NULL
22°C	NULL
,	NULL
then	NULL
transferred	NULL
to	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
9A7y	NULL
antibody	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
shaken	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
by	NULL
gently	NULL
shaking	NULL
for	NULL
20	NULL
min	NULL
at	NULL
22°C	NULL
in	NULL
100	NULL
ml	NULL
of	NULL
TBS	NULL
(	NULL
0.01	NULL
M	NULL
TrissHClI	NULL
,	NULL
pH	NULL
7.2/0.15	NULL
M	NULL
NaCl	NULL
)	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
;	NULL
this	NULL
step	NULL
was	NULL
repeated	NULL
four	NULL
times	NULL
.	NULL

After	NULL
a	NULL
2-	NULL
to	NULL
4-hr	NULL
preincubation	NULL
in	NULL
PBS/3	NULL
%	NULL
BSA	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
reincubated	NULL
overnight	NULL
at	NULL
4°C	NULL
in	NULL
PBS/1	NULL
%	NULL
BSA	NULL
containing	NULL
the	NULL
secondary	NULL
antibody	NULL
(	NULL
rabbit	NULL
anti-rat	NULL
IgG	NULL
,	NULL
1:2000	NULL
dilution	NULL
from	NULL
1	NULL
mg/ml	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
then	NULL
washed	NULL
again	NULL
as	NULL
described	NULL
above	NULL
,	NULL
preincubated	NULL
in	NULL
PBS/0.3	NULL
%	NULL
BSA	NULL
for	NULL
2-4	NULL
hr	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
radioiodinated	NULL
protein	NULL
A	NULL
(	NULL
0.21	NULL
LCi/	NULL
ml	NULL
)	NULL
in	NULL
PBS/1	NULL
%	NULL
BSA	NULL
for	NULL
3	NULL
hr	NULL
at	NULL
22°C	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
dried	NULL
and	NULL
then	NULL
autoradiographed	NULL
at	NULL
-70°C	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
on	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
film	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
density	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
determined	NULL
by	NULL
transmission	NULL
scanning	NULL
laser	NULL
den-sitometry	NULL
using	NULL
the	NULL
Bio-Rad	NULL
model	NULL
620	NULL
densitometer	NULL
and	NULL
a	NULL
software	NULL
package	NULL
provided	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Background	NULL
was	NULL
subtracted	NULL
by	NULL
setting	NULL
the	NULL
base	NULL
line	NULL
between	NULL
the	NULL
lanes	NULL
of	NULL
the	NULL
gel	NULL
at	NULL
0	NULL
.	NULL

RESULTS	NULL
Representative	NULL
findings	NULL
from	NULL
immunoblots	NULL
of	NULL
crude	NULL
cytosol	NULL
preparations	NULL
from	NULL
PBMCs	NULL
using	NULL
the	NULL
anti-VDR	NULL
monoclonal	NULL
antibody	NULL
9A77	NULL
are	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
with	NULL
a	NULL
relatively	NULL
short	NULL
exposure	NULL
(	NULL
15	NULL
hr	NULL
)	NULL
,	NULL
we	NULL
detected	NULL
a	NULL
protein	NULL
band	NULL
with	NULL
an	NULL
approximate	NULL
migration	NULL
position	NULL
of	NULL
80	NULL
kDa	NULL
.	NULL

This	NULL
80-kDa	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
the	NULL
cytosol	NULL
preparations	NULL
of	NULL
PBMCs	NULL
that	NULL
had	NULL
been	NULL
activated	NULL
by	NULL
a	NULL
72-hr	NULL
incubation	NULL
with	NULL
the	NULL
mitogenic	NULL
lectin	NULL
PHA	NULL
or	NULL
the	NULL
OKT3	NULL
antibody	NULL
to	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
OKT3	NULL
)	NULL
;	NULL
however	NULL
,	NULL
this	NULL
80-kDa	NULL
protein	NULL
was	NULL
absent	NULL
in	NULL
cytosols	NULL
from	NULL
PBMCs	NULL
that	NULL
had	NULL
not	NULL
been	NULL
exposed	NULL
to	NULL
the	NULL
activation	NULL
agents	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
this	NULL
protein	NULL
was	NULL
confirmed	NULL
in	NULL
a	NULL
large	NULL
series	NULL
of	NULL
normal	NULL
human	NULL
activated	NULL
PBMC	NULL
samples	NULL
(	NULL
n	NULL
>	NULL
30	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
80-kDa	NULL
species	NULL
,	NULL
which	NULL
was	NULL
readily	NULL
recognized	NULL
by	NULL
the	NULL
9A77	NULL
anti-VDR	NULL
antibody	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
detect	NULL
a	NULL
weaker	NULL
band	NULL
migrating	NULL
at	NULL
50	NULL
kDa	NULL
,	NULL
the	NULL
expected	NULL
position	NULL
of	NULL
the	NULL
VDR	NULL
,	NULL
only	NULL
after	NULL
a	NULL
longer	NULL
exposure	NULL
(	NULL
120	NULL
hr	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

18	NULL
)	NULL
.	NULL

The	NULL
50-kDa	NULL
species	NULL
comigrated	NULL
with	NULL
enriched	NULL
preparations	NULL
of	NULL
human	NULL
intestinal	NULL
VDR	NULL
.	NULL

Consistent	NULL
with	NULL
evidence	NULL
from	NULL
earlier	NULL
binding	NULL
studies	NULL
(	NULL
2	NULL
)	NULL
and	NULL
similar	NULL
to	NULL
the	NULL
80-kDa	NULL
protein	NULL
,	NULL
the	NULL
50-kDa	NULL
lymphocyte	NULL
VDR	NULL
was	NULL
absent	NULL
from	NULL
resting	NULL
but	NULL
present	NULL
in	NULL
activated	NULL
cells	NULL
.	NULL

**	NULL
*	NULL
%	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Immunologic	NULL
detection	NULL
of	NULL
the	NULL
VDR	NULL
and	NULL
an	NULL
80-kDa	NULL
protein	NULL
in	NULL
activated	NULL
human	NULL
lymphocytes	NULL
by	NULL
anti-VDR	NULL
antibody	NULL
.	NULL

PBMCs	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll	NULL
gradient	NULL
centrifugation	NULL
and	NULL
incubated	NULL
for	NULL
72	NULL
hr	NULL
without	NULL
stimuli	NULL
or	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
or	NULL
with	NULL
the	NULL
antibody	NULL
OKT3	NULL
(	NULL
1:250	NULL
dilution	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
at	NULL
pH	NULL
7.4	NULL
and	NULL
sonicated	NULL
,	NULL
and	NULL
the	NULL
sonicate	NULL
was	NULL
centrifuged	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
105,000	NULL
x	NULL
g.	NULL
Samples	NULL
of	NULL
the	NULL
cytosol	NULL
(	NULL
containing	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
and	NULL
an	NULL
enriched	NULL
preparation	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
VDR	NULL
from	NULL
transfected	NULL
COS	NULL
cells	NULL
(	NULL
~15	NULL
fmol	NULL
of	NULL
VDR	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
SDS/PAGE	NULL
and	NULL
then	NULL
to	NULL
immunoblot	NULL
analysis	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
PBS	NULL
at	NULL
pH	NULL
7.2	NULL
containing	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
the	NULL
9A7y	NULL
monoclonal	NULL
antibody	NULL
(	NULL
2	NULL
ug/ml	NULL
!	NULL
)	NULL

overnight	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
TBS	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
%	NULL
BSA/PBS	NULL
at	NULL
pH	NULL
7.2	NULL
containing	NULL
the	NULL
secondary	NULL
antibody	NULL
[	NULL
rabbit	NULL
anti-rat	NULL
IgG	NULL
,	NULL
1:2000	NULL
dilution	NULL
from	NULL
a	NULL
stock	NULL
solution	NULL
(	NULL
1	NULL
mg/ml	NULL
)	NULL
]	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
again	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
radioiodinated	NULL
protein	NULL
A	NULL
for	NULL
3	NULL
hr	NULL
at	NULL
22°C	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
dried	NULL
and	NULL
then	NULL
autoradiographed	NULL
at	NULL
-70°C	NULL
on	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
film	NULL
for	NULL
15	NULL
hr	NULL
(	NULL
4	NULL
)	NULL
or	NULL
120	NULL
hr	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Blots	NULL
in	NULL
A	NULL
and	NULL
B	NULL
were	NULL
derived	NULL
from	NULL
different	NULL
gels	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Lanes	NULL
:	NULL
1	NULL
,	NULL
molecular	NULL
mass	NULL
markers	NULL
;	NULL
2	NULL
,	NULL
no	NULL
stimulus	NULL
;	NULL
3	NULL
,	NULL
PHA	NULL
added	NULL
;	NULL
4	NULL
,	NULL
OKT3	NULL
added	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Lanes	NULL
:	NULL
1	NULL
,	NULL
molecular	NULL
mass	NULL
markers	NULL
;	NULL
2	NULL
,	NULL
pure	NULL
VDR	NULL
;	NULL
3	NULL
,	NULL
no	NULL
stimulus	NULL
;	NULL
4	NULL
,	NULL
PHA	NULL
added	NULL
;	NULL
5	NULL
,	NULL
OKT3	NULL
added	NULL
;	NULL
6	NULL
,	NULL
pure	NULL
VDR	NULL
.	NULL

Immunology	NULL
:	NULL
Yu	NULL
et	NULL
al	NULL
.	NULL

To	NULL
gain	NULL
more	NULL
information	NULL
on	NULL
this	NULL
serendipitously	NULL
discovered	NULL
80-kDa	NULL
species	NULL
,	NULL
PBMCs	NULL
from	NULL
normal	NULL
donors	NULL
were	NULL
activated	NULL
with	NULL
PHA	NULL
,	NULL
and	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
protein	NULL
and	NULL
its	NULL
localization	NULL
in	NULL
various	NULL
cell	NULL
fractions	NULL
were	NULL
determined	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
80-kDa	NULL
species	NULL
was	NULL
not	NULL
detected	NULL
4	NULL
hr	NULL
after	NULL
lymphocyte	NULL
activation	NULL
but	NULL
was	NULL
detected	NULL
24	NULL
hr	NULL
after	NULL
activation	NULL
,	NULL
and	NULL
its	NULL
abundance	NULL
appeared	NULL
to	NULL
increase	NULL
in	NULL
a	NULL
time-dependent	NULL
fashion	NULL
over	NULL
the	NULL
next	NULL
48	NULL
hr	NULL
.	NULL

In	NULL
this	NULL
and	NULL
the	NULL
subsequent	NULL
experiments	NULL
where	NULL
,	NULL
instead	NULL
of	NULL
10	NULL
%	NULL
gels	NULL
,	NULL
7.5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
were	NULL
used	NULL
to	NULL
prepare	NULL
the	NULL
immunoblots	NULL
,	NULL
the	NULL
80-kDa	NULL
species	NULL
appeared	NULL
as	NULL
a	NULL
doublet	NULL
with	NULL
the	NULL
slower	NULL
migrating	NULL
band	NULL
being	NULL
predominant	NULL
.	NULL

The	NULL
faint	NULL
band	NULL
seen	NULL
at	NULL
92.5	NULL
kDa	NULL
in	NULL
this	NULL
and	NULL
some	NULL
of	NULL
the	NULL
later	NULL
experiments	NULL
was	NULL
not	NULL
a	NULL
consistent	NULL
finding	NULL
,	NULL
nor	NULL
was	NULL
this	NULL
band	NULL
regulated	NULL
in	NULL
any	NULL
specific	NULL
manner	NULL
.	NULL

The	NULL
80-kDa	NULL
doublet	NULL
was	NULL
localized	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
activated	NULL
PBMCs	NULL
,	NULL
since	NULL
immunoblots	NULL
of	NULL
proteins	NULL
extracted	NULL
from	NULL
the	NULL
membrane	NULL
and	NULL
nuclear	NULL
fractions	NULL
of	NULL
the	NULL
same	NULL
cells	NULL
lacked	NULL
these	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
80-kDa	NULL
species	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
membrane	NULL
fractions	NULL
of	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
activated	NULL
by	NULL
PHA	NULL
from	NULL
0	NULL
to	NULL
72	NULL
hr	NULL
,	NULL
thus	NULL
eliminating	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
80-kDa	NULL
protein	NULL
was	NULL
expressed	NULL
first	NULL
in	NULL
the	NULL
membrane	NULL
of	NULL
activated	NULL
lymphocytes	NULL
and	NULL
then	NULL
translocated	NULL
to	NULL
the	NULL
cytosol	NULL
.	NULL

In	NULL
parallel	NULL
studies	NULL
to	NULL
those	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
localization	NULL
of	NULL
the	NULL
VDR	NULL
in	NULL
the	NULL
same	NULL
fractions	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
1,25	NULL
(	NULL
PH	NULL
]	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
80-kDa	NULL
species	NULL
,	NULL
binding	NULL
of	NULL
the	NULL
ligand	NULL
to	NULL
its	NULL
receptor	NULL
(	NULL
determined	NULL
by	NULL
sucrose	NULL
density	NULL
centrifugation	NULL
analysis	NULL
)	NULL
was	NULL
present	NULL
exclusively	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
.	NULL

Results	NULL
of	NULL
studies	NULL
to	NULL
determine	NULL
the	NULL
cell-type	NULL
specificity	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
are	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
80-kDa	NULL
protein	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
activated	NULL
lymphocytes	NULL
since	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
other	NULL
VDR-bearing	NULL
human	NULL
cells	NULL
such	NULL
as	NULL
the	NULL
promyelocytic	NULL
leukemic	NULL
cells	NULL
(	NULL
HL-60	NULL
)	NULL
,	NULL
kidney	NULL
cortex	NULL
,	NULL
brain	NULL
tissue	NULL
,	NULL
and	NULL
osteoblast-like	NULL
cells	NULL
(	NULL
SAOS-2	NULL
)	NULL
.	NULL

The	NULL
80-kDa	NULL
protein	NULL
was	NULL
also	NULL
not	NULL
detected	NULL
in	NULL
normal	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
monocytes	NULL
heated	NULL
(	NULL
to	NULL
express	NULL
the	NULL
heat-shock	NULL
protein	NULL
)	NULL
or	NULL
activated	NULL
with	NULL
LPS	NULL
.	NULL

The	NULL
latter	NULL
finding	NULL
establishes	NULL
clearly	NULL
that	NULL
the	NULL
source	NULL
of	NULL
the	NULL
protein	NULL
in	NULL
the	NULL
experiments	NULL
with	NULL
mixed	NULL
PBMCs	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
monocytes	NULL
and	NULL
lymphocytes	NULL
)	NULL
is	NULL
indeed	NULL
the	NULL
activated	NULL
lymphocyte	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
might	NULL
influence	NULL
the	NULL
expression	NULL
of	NULL
either	NULL
the	NULL
80-kDa	NULL
protein	NULL
or	NULL
the	NULL
50-kDa	NULL
VDR	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
prompted	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
ligand	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
upregulates	NULL
its	NULL
own	NULL
receptor	NULL
in	NULL
the	NULL
classical	NULL
target	NULL
tissues	NULL
of	NULL
the	NULL
hormone	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
PBMCs	NULL
from	NULL
normal	NULL
donors	NULL
were	NULL
activated	NULL
with	NULL
PHA	NULL
or	NULL
OKT3	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

As	NULL
in	NULL
the	NULL
previous	NULL
experiments	NULL
,	NULL
the	NULL
80-kDa	NULL
protein	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
resting	NULL
lymphocytes	NULL
but	NULL
was	NULL
readily	NULL
detected	NULL
in	NULL
activated	NULL
cells	NULL
.	NULL

Nevertheless	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
the	NULL
50-kDa	NULL
band	NULL
became	NULL
apparent	NULL
and	NULL
was	NULL
upregulated	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
5-fold	NULL
increase	NULL
at	NULL
10	NULL
nM	NULL
)	NULL
in	NULL
PHA	NULL
92.5	NULL
§	NULL
``	NULL
4	NULL
_j	NULL
w	NULL
#	NULL
69	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
in	NULL
activated	NULL
lymphocytes	NULL
.	NULL

PBMCs	NULL
isolated	NULL
by	NULL
Ficoll/Paque	NULL
were	NULL
activated	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
harvested	NULL
at	NULL
various	NULL
times	NULL
after	NULL
PHA	NULL
addition	NULL
as	NULL
follows	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
4	NULL
hr	NULL
;	NULL
2	NULL
,	NULL
24	NULL
hr	NULL
;	NULL
3	NULL
,	NULL
48	NULL
hr	NULL
;	NULL
4	NULL
,	NULL
72	NULL
hr	NULL
.	NULL

Cytosol	NULL
fractions	NULL
(	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
obtained	NULL
by	NULL
ultracentrif-ugation	NULL
were	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
probed	NULL
with	NULL
the	NULL
9A77	NULL
antibody	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
radioiodinated	NULL
protein	NULL
A	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
autoradiogram	NULL
was	NULL
exposed	NULL
for	NULL
24	NULL
hr	NULL
at	NULL
-70°C	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
8349	NULL
69	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Subcellular	NULL
distribution	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
.	NULL

PBMCs	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll/Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
activated	NULL
for	NULL
72	NULL
hr	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
.	NULL

Subcellular	NULL
fractions	NULL
(	NULL
cytosol	NULL
,	NULL
nuclei	NULL
,	NULL
and	NULL
membrane	NULL
)	NULL
were	NULL
separated	NULL
,	NULL
subjected	NULL
to	NULL
SDS/PAGE	NULL
,	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
for	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
nuclear	NULL
fraction	NULL
;	NULL
2	NULL
,	NULL
cytosolic	NULL
fraction	NULL
;	NULL
3	NULL
,	NULL
membrane	NULL
fraction	NULL
.	NULL

and	NULL
in	NULL
OKT3-activated	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
50-kDa	NULL
protein	NULL
,	NULL
however	NULL
,	NULL
the	NULL
80-kDa	NULL
doublet	NULL
was	NULL
downregulated	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
5-fold	NULL
decrease	NULL
at	NULL
10	NULL
nM	NULL
)	NULL
.	NULL

Downregulation	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
was	NULL
a	NULL
consistent	NULL
finding	NULL
confirmed	NULL
in	NULL
more	NULL
than	NULL
12	NULL
lymphocytes	NULL
preparations	NULL
from	NULL
the	NULL
various	NULL
donors	NULL
we	NULL
have	NULL
examined	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
downregulatory	NULL
effect	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
the	NULL
80-kDa	NULL
doublet	NULL
was	NULL
independent	NULL
of	NULL
the	NULL
mode	NULL
of	NULL
lymphocyte	NULL
activation	NULL
since	NULL
it	NULL
was	NULL
present	NULL
in	NULL
both	NULL
PHA-	NULL
and	NULL
OKT3-activated	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
the	NULL
results	NULL
of	NULL
the	NULL
experiments	NULL
of	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
the	NULL
inverse	NULL
effects	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
the	NULL
50-kDa	NULL
and	NULL
80-kDa	NULL
proteins	NULL
were	NULL
specific	NULL
for	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
since	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
and	NULL
24,25-	NULL
5	NULL
,	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Cell-type	NULL
specificity	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
.	NULL

PBMCs	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll	NULL
gradient	NULL
centrifugation	NULL
and	NULL
activated	NULL
for	NULL
72	NULL
hr	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
.	NULL

Enriched	NULL
monocytes	NULL
from	NULL
PBMCs	NULL
were	NULL
obtained	NULL
by	NULL
collecting	NULL
the	NULL
adherent	NULL
cells	NULL
after	NULL
a	NULL
1-hr	NULL
incubation	NULL
or	NULL
subjecting	NULL
PBMCs	NULL
to	NULL
Percoll	NULL
gradient	NULL
separation	NULL
;	NULL
cells	NULL
were	NULL
then	NULL
either	NULL
heat-shocked	NULL
at	NULL
45°C	NULL
for	NULL
20	NULL
min	NULL
or	NULL
stimulated	NULL
for	NULL
72	NULL
hr	NULL
with	NULL
LPS	NULL
at	NULL
10	NULL
ug/ml	NULL
.	NULL

Human	NULL
kidney	NULL
cortex	NULL
and	NULL
brain	NULL
were	NULL
minced	NULL
,	NULL
homogenized	NULL
in	NULL
KETD-0.3	NULL
,	NULL
and	NULL
briefly	NULL
centrifuged	NULL
at	NULL
1000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
sonicates	NULL
of	NULL
PHA-activated	NULL
PBMC	NULL
,	NULL
heat-shocked	NULL
and	NULL
LPS-stimulated	NULL
monocytes	NULL
,	NULL
human	NULL
promyelocytic	NULL
leukemic	NULL
cells	NULL
(	NULL
HL-60	NULL
)	NULL
,	NULL
osteoblastic	NULL
human	NULL
osteosarcoma	NULL
cell	NULL
line	NULL
(	NULL
SAOS-2	NULL
)	NULL
,	NULL
and	NULL
homegenates	NULL
of	NULL
human	NULL
kidney	NULL
and	NULL
brain	NULL
were	NULL
centrifuged	NULL
at	NULL
105,000	NULL
x	NULL
g	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

Samples	NULL
of	NULL
the	NULL
cytosol	NULL
containing	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
were	NULL
subjected	NULL
to	NULL
SDS/PAGE	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
for	NULL
immunoblot	NULL
analysis	NULL
.	NULL

8350	NULL
Immunology	NULL
:	NULL
Yu	NULL
et	NULL
al	NULL
.	NULL

«	NULL
.	NULL

*	NULL
--	NULL
a	NULL
FiG	NULL
.	NULL

5	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
VDR	NULL
and	NULL
the	NULL
80-kDa	NULL
protein	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

PBMCs	NULL
isolated	NULL
by	NULL
Ficoll/Paque	NULL
centrifugation	NULL
were	NULL
incubated	NULL
for	NULL
72	NULL
hr	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
or	NULL
OKT	NULL
3	NULL
(	NULL
1:250	NULL
dilution	NULL
)	NULL
and	NULL
various	NULL
concentrations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
sonicated	NULL
.	NULL

Cytosol	NULL
was	NULL
obtained	NULL
by	NULL
ultracen-trifugation	NULL
.	NULL

Samples	NULL
of	NULL
cytosol	NULL
(	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
SDS/PAGE	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
for	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
enriched	NULL
preparation	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
VDR	NULL
(	NULL
15	NULL
fmol	NULL
)	NULL
;	NULL
2	NULL
,	NULL
cytosol	NULL
from	NULL
nonstimulated	NULL
lymphocytes	NULL
;	NULL
3-6	NULL
,	NULL
cytosols	NULL
from	NULL
lymphocyte	NULL
activated	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
!	NULL
)	NULL

alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
nM	NULL
,	NULL
1	NULL
nM	NULL
,	NULL
or	NULL
10	NULL
nM	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
respectively	NULL
;	NULL
7-10	NULL
,	NULL
cytosols	NULL
from	NULL
lymphocytes	NULL
activated	NULL
with	NULL
OKT3	NULL
(	NULL
1:250	NULL
dilution	NULL
)	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
nM	NULL
,	NULL
1	NULL
nM	NULL
,	NULL
or	NULL
10	NULL
nM	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
respectively	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
VDR	NULL
and	NULL
the	NULL
80-kDa	NULL
proteins	NULL
.	NULL

dihydroxyvitamin	NULL
D	NULL
;	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
either	NULL
band	NULL
.	NULL

Estrogens	NULL
also	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

However	NULL
,	NULL
two	NULL
potent	NULL
immunosuppressive	NULL
agents	NULL
,	NULL
the	NULL
synthetic	NULL
glucocorticoid	NULL
triamcinolone	NULL
acetonide	NULL
and	NULL
cyclosporin	NULL
A	NULL
,	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
80-kDa	NULL
doublet	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Intriguingly	NULL
,	NULL
cyclosporin	NULL
A	NULL
,	NULL
but	NULL
not	NULL
the	NULL
synthetic	NULL
glucocorticoid	NULL
,	NULL
appeared	NULL
to	NULL
upregulate	NULL
the	NULL
50-kDa	NULL
VDR	NULL
.	NULL

DISCUSSION	NULL
Activation	NULL
of	NULL
human	NULL
and	NULL
animal	NULL
lymphocytes	NULL
,	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
,	NULL
leads	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
VDR	NULL
,	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
influences	NULL
the	NULL
immune	NULL
function	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
suggest	NULL
another	NULL
aspect	NULL
of	NULL
interaction	NULL
between	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
lymphocytes	NULL
.	NULL

Specifically	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
lymphocyte	NULL
activation	NULL
leads	NULL
not	NULL
only	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
VDR	NULL
but	NULL
also	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
protein	NULL
with	NULL
the	NULL
approximate	NULL
molecular	NULL
mass	NULL
of	NULL
80	NULL
kDa	NULL
that	NULL
shares	NULL
immunologic	NULL
crossreactivity	NULL
with	NULL
the	NULL
VDR	NULL
since	NULL
it	NULL
was	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
VDR	NULL
and	NULL
the	NULL
80-kDa	NULL
protein	NULL
.	NULL

PBMCs	NULL
isolated	NULL
by	NULL
Ficoll/Paque	NULL
centrifugation	NULL
were	NULL
incubated	NULL
for	NULL
72	NULL
hr	NULL
without	NULL
stimuli	NULL
or	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
M	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
1,25D	NULL
;	NULL
)	NULL
,	NULL
10	NULL
nM	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
(	NULL
25D	NULL
;	NULL
)	NULL
,	NULL
10	NULL
nM	NULL
24,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
(	NULL
24,25D	NULL
;	NULL
)	NULL
,	NULL
10	NULL
nM	NULL
17B-estradiol	NULL
(	NULL
1786-E	NULL
;	NULL
)	NULL
,	NULL
10	NULL
nM	NULL
triamcinolone	NULL
acetonide	NULL
(	NULL
TRM	NULL
)	NULL
,	NULL
or	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
;	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

Cytosols	NULL
were	NULL
obtained	NULL
by	NULL
ultracen-trifuge	NULL
after	NULL
incubation	NULL
.	NULL

Samples	NULL
of	NULL
cytosol	NULL
(	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
for	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
VDR	NULL
and	NULL
the	NULL
80-kDa	NULL
protein	NULL
.	NULL

Positions	NULL
of	NULL
molecular	NULL
mass	NULL
standards	NULL
(	NULL
MWM	NULL
in	NULL
kDa	NULL
)	NULL
are	NULL
also	NULL
indicated	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
detected	NULL
by	NULL
the	NULL
9A77y	NULL
monoclonal	NULL
antibody	NULL
,	NULL
which	NULL
was	NULL
raised	NULL
against	NULL
the	NULL
VDR	NULL
.	NULL

This	NULL
antibody	NULL
recognizes	NULL
a	NULL
17-amino	NULL
acid	NULL
epitope	NULL
near	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
VDR	NULL
(	NULL
18	NULL
)	NULL
.	NULL

We	NULL
determined	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
that	NULL
a	NULL
dilution	NULL
of	NULL
the	NULL
9A7y	NULL
antibody	NULL
as	NULL
low	NULL
as	NULL
1:10,000	NULL
can	NULL
readily	NULL
detect	NULL
this	NULL
lymphocyte	NULL
protein	NULL
on	NULL
immunoblots	NULL
.	NULL

Since	NULL
no	NULL
known	NULL
mammalian	NULL
protein	NULL
of	NULL
comparable	NULL
molecular	NULL
size	NULL
contains	NULL
a	NULL
sequence	NULL
with	NULL
significant	NULL
homology	NULL
with	NULL
the	NULL
17-amino	NULL
acid	NULL
epitope	NULL
of	NULL
the	NULL
anti-VDR	NULL
antibody	NULL
(	NULL
determined	NULL
by	NULL
search	NULL
of	NULL
the	NULL
National	NULL
Biomedical	NULL
Research	NULL
Foundation	NULL
protein	NULL
data	NULL
base	NULL
on	NULL
June	NULL
4	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
this	NULL
protein	NULL
has	NULL
not	NULL
been	NULL
previously	NULL
sequenced	NULL
.	NULL

Intriguingly	NULL
,	NULL
however	NULL
,	NULL
the	NULL
epitope	NULL
recognized	NULL
by	NULL
this	NULL
antibody	NULL
contains	NULL
a	NULL
7-amino	NULL
acid	NULL
stretch	NULL
(	NULL
EEVQRKR	NULL
)	NULL
that	NULL
is	NULL
identical	NULL
to	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
50-kDa	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
19	NULL
)	NULL
.	NULL

We	NULL
have	NULL
internalized	NULL
the	NULL
9A77	NULL
antibody	NULL
into	NULL
intact	NULL
PBMCs	NULL
and	NULL
,	NULL
using	NULL
cytofluo-rometric	NULL
analysis	NULL
,	NULL
have	NULL
determined	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
epitope	NULL
has	NULL
a	NULL
different	NULL
time	NULL
course	NULL
than	NULL
binding	NULL
of	NULL
1,25	NULL
[	NULL
°H	NULL
]	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
the	NULL
VDR	NULL
,	NULL
which	NULL
was	NULL
determined	NULL
earlier	NULL
(	NULL
ref	NULL
.	NULL

20	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Thus	NULL
it	NULL
appears	NULL
likely	NULL
that	NULL
the	NULL
9A7y	NULL
antibody	NULL
recognizes	NULL
not	NULL
only	NULL
the	NULL
denatured	NULL
80-kDa	NULL
protein	NULL
but	NULL
also	NULL
the	NULL
native	NULL
protein	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
and	NULL
its	NULL
role	NULL
in	NULL
the	NULL
biology	NULL
of	NULL
lymphocytes	NULL
are	NULL
unknown	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
strong	NULL
immunologic	NULL
crossreactivity	NULL
between	NULL
the	NULL
VDR	NULL
and	NULL
the	NULL
80-kDa	NULL
protein	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
two	NULL
proteins	NULL
might	NULL
be	NULL
related	NULL
.	NULL

Several	NULL
pieces	NULL
of	NULL
evidence	NULL
,	NULL
however	NULL
,	NULL
argue	NULL
against	NULL
this	NULL
possibility	NULL
.	NULL

(	NULL
?	NULL
)	NULL

There	NULL
is	NULL
evidence	NULL
(	NULL
J.	NULL
W.	NULL
Pike	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
that	NULL
the	NULL
VDR	NULL
is	NULL
not	NULL
comprised	NULL
of	NULL
multiple	NULL
products	NULL
either	NULL
resulting	NULL
from	NULL
alternative	NULL
processing	NULL
or	NULL
derived	NULL
from	NULL
mulitiple	NULL
genes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
no	NULL
clones	NULL
were	NULL
found	NULL
that	NULL
were	NULL
partially	NULL
related	NULL
to	NULL
the	NULL
VDR	NULL
during	NULL
the	NULL
screening	NULL
of	NULL
several	NULL
chicken	NULL
cDNA	NULL
libraries	NULL
and	NULL
three	NULL
human	NULL
libraries	NULL
from	NULL
fibroblasts	NULL
,	NULL
the	NULL
breast	NULL
carcinoma	NULL
line	NULL
T47D	NULL
,	NULL
or	NULL
monocytes	NULL
(	NULL
J.	NULL
W.	NULL
Pike	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
We	NULL
amplified	NULL
and	NULL
sequenced	NULL
cDNA	NULL
from	NULL
activated	NULL
PBMCs	NULL
by	NULL
using	NULL
primers	NULL
that	NULL
flank	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
VDR	NULL
(	NULL
21	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
antigenic	NULL
epitope	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
amplified	NULL
sequence	NULL
had	NULL
an	NULL
exact	NULL
homology	NULL
with	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
VDR	NULL
sequence	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
we	NULL
were	NULL
able	NULL
to	NULL
obtain	NULL
an	NULL
unambiguous	NULL
sequence	NULL
in	NULL
those	NULL
studies	NULL
argues	NULL
also	NULL
against	NULL
the	NULL
possibility	NULL
that	NULL
there	NULL
might	NULL
be	NULL
closely	NULL
related	NULL
mRNAs	NULL
to	NULL
the	NULL
VDR	NULL
mRNA	NULL
in	NULL
activated	NULL
lymphocytes	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Evidence	NULL
against	NULL
the	NULL
relatedness	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
comes	NULL
from	NULL
the	NULL
present	NULL
study	NULL
that	NULL
shows	NULL
that	NULL
the	NULL
80-kDa	NULL
protein	NULL
is	NULL
absent	NULL
from	NULL
VDR-positive	NULL
human	NULL
cells	NULL
other	NULL
than	NULL
activated	NULL
lymphocytes	NULL
.	NULL

More	NULL
intriguing	NULL
than	NULL
the	NULL
recognition	NULL
of	NULL
an	NULL
activation-induced	NULL
protein	NULL
in	NULL
lymphocytes	NULL
with	NULL
immunologic	NULL
crossreactivity	NULL
with	NULL
the	NULL
VDR	NULL
is	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
former	NULL
species	NULL
is	NULL
subject	NULL
to	NULL
regulation	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
as	NULL
is	NULL
the	NULL
receptor	NULL
itself	NULL
,	NULL
especially	NULL
,	NULL
since	NULL
the	NULL
downregulatory	NULL
effect	NULL
of	NULL
the	NULL
hormone	NULL
on	NULL
the	NULL
80-kDa	NULL
protein	NULL
is	NULL
exactly	NULL
opposite	NULL
to	NULL
the	NULL
upregulatory	NULL
effect	NULL
of	NULL
the	NULL
ligand	NULL
on	NULL
its	NULL
own	NULL
receptor	NULL
.	NULL

The	NULL
inverse	NULL
effects	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
these	NULL
two	NULL
proteins	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
a	NULL
precursor-product	NULL
relationship	NULL
exists	NULL
between	NULL
the	NULL
80-kDa	NULL
protein	NULL
and	NULL
the	NULL
VDR	NULL
.	NULL

However	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
time	NULL
course	NULL
of	NULL
their	NULL
appearance	NULL
,	NULL
the	NULL
80-kDa	NULL
being	NULL
slower	NULL
to	NULL
appear	NULL
,	NULL
and	NULL
the	NULL
evidence	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
former	NULL
is	NULL
not	NULL
associated	NULL
with	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
latter	NULL
by	NULL
glucocorticoids	NULL
point	NULL
away	NULL
from	NULL
the	NULL
precursor-product	NULL
relationship	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
upregulate	NULL
its	NULL
own	NULL
receptor	NULL
has	NULL
not	NULL
been	NULL
previously	NULL
demonstrated	NULL
in	NULL
lymphocytes	NULL
.	NULL

However	NULL
,	NULL
hormone-induced	NULL
upregulation	NULL
of	NULL
the	NULL
VDR	NULL
has	NULL
been	NULL
demonstrated	NULL
(	NULL
15-17	NULL
)	NULL
in	NULL
the	NULL
classical	NULL
target	NULL
tissues	NULL
of	NULL
the	NULL
hormone	NULL
.	NULL

Therefore	NULL
,	NULL
VDR	NULL
upregulation	NULL
Immunology	NULL
:	NULL
Yu	NULL
et	NULL
al	NULL
.	NULL

by	NULL
its	NULL
ligand	NULL
is	NULL
a	NULL
universal	NULL
occurrence	NULL
in	NULL
both	NULL
the	NULL
classical	NULL
and	NULL
the	NULL
more	NULL
recently	NULL
discovered	NULL
target	NULL
tissues	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
other	NULL
metabolites	NULL
of	NULL
vitamin	NULL
D	NULL
;	NULL
,	NULL
with	NULL
lower	NULL
affinities	NULL
for	NULL
the	NULL
VDR	NULL
,	NULL
failed	NULL
to	NULL
upregulate	NULL
the	NULL
receptor	NULL
at	NULL
concentrations	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
suggests	NULL
that	NULL
this	NULL
effect	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
receptor	NULL
itself	NULL
,	NULL
presumably	NULL
through	NULL
recognition	NULL
of	NULL
the	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
VDR	NULL
gene	NULL
.	NULL

The	NULL
similar	NULL
specificity	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
other	NULL
vitamin	NULL
D	NULL
metabolites	NULL
on	NULL
the	NULL
downregulation	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
also	NULL
points	NULL
to	NULL
a	NULL
regeptor-mediated	NULL
mechanism	NULL
.	NULL

This	NULL
is	NULL
particularly	NULL
im-portant	NULL
,	NULL
since	NULL
unlike	NULL
previously	NULL
reported	NULL
effects	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
lymphocytes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
effects	NULL
on	NULL
interleukin	NULL
2	NULL
production	NULL
and	NULL
proliferation	NULL
,	NULL
both	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
VDR	NULL
and	NULL
the	NULL
80-kDa	NULL
protein	NULL
were	NULL
independent	NULL
of	NULL
the	NULL
mode	NULL
of	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Indeed	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
regulated	NULL
both	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
cells	NULL
activated	NULL
by	NULL
PHA	NULL
or	NULL
by	NULL
OKT3	NULL
.	NULL

As	NULL
we	NULL
have	NULL
reported	NULL
(	NULL
1	NULL
)	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
proliferative	NULL
response	NULL
of	NULL
OKT3-activated	NULL
lymphocytes	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
downregulation	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
may	NULL
be	NULL
a	NULL
primary	NULL
effect	NULL
and	NULL
not	NULL
the	NULL
result	NULL
of	NULL
hormonal	NULL
interference	NULL
with	NULL
lymphocyte	NULL
proliferation	NULL
.	NULL

Fur-thermore	NULL
,	NULL
the	NULL
downregulation	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
in	NULL
OKT3-activated	NULL
cells	NULL
points	NULL
away	NULL
from	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
protein	NULL
is	NULL
involved	NULL
in	NULL
lymphocyte	NULL
proliferation	NULL
.	NULL

Unlike	NULL
the	NULL
nonhormonal	NULL
metabolites	NULL
pf	NULL
vitamin	NULL
D	NULL
;	NULL
and	NULL
the	NULL
steroid	NULL
hormone	NULL
17B-estradiol	NULL
,	NULL
we	NULL
have	NULL
found	NULL
evidence	NULL
that	NULL
glucocorticoids	NULL
and	NULL
cyclosporin	NULL
A	NULL
exerted	NULL
a	NULL
dqownregulatory	NULL
effect	NULL
on	NULL
the	NULL
80-kDa	NULL
protein	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
these	NULL
observations	NULL
is	NULL
,	NULL
so	NULL
far	NULL
,	NULL
unclear	NULL
.	NULL

Nevertheless	NULL
,	NULL
since	NULL
two	NULL
steroid	NULL
hormones	NULL
with	NULL
known	NULL
immunoregulatory	NULL
properties	NULL
[	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
glu-cocorticoids	NULL
]	NULL
and	NULL
a	NULL
pharmacologic	NULL
agent	NULL
with	NULL
strong	NULL
immunosuppressive	NULL
actions	NULL
(	NULL
cyclosporin	NULL
A	NULL
)	NULL
(	NULL
22	NULL
)	NULL
share	NULL
this	NULL
effect	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
80-kDa	NULL
protein	NULL
has	NULL
an	NULL
important	NULL
role	NULL
in	NULL
immune	NULL
phenomena	NULL
.	NULL

This	NULL
protein	NULL
might	NULL
also	NULL
be	NULL
a	NULL
critical	NULL
target	NULL
for	NULL
immunosuppressive	NULL
therapies	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
have	NULL
provided	NULL
evidence	NULL
for	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
protein	NULL
in	NULL
lymphocytes	NULL
that	NULL
is	NULL
activation-induced	NULL
,	NULL
shares	NULL
immunologic	NULL
crossreactivity	NULL
with	NULL
the	NULL
VDR	NULL
,	NULL
and	NULL
is	NULL
downregulated	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
as	NULL
opposed	NULL
to	NULL
the	NULL
VDR	NULL
,	NULL
which	NULL
is	NULL
upregulated	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
these	NULL
studies	NULL
add	NULL
a	NULL
link	NULL
in	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
vitamin	NULL
D	NULL
endocrine	NULL
system	NULL
and	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

We	NULL
expect	NULL
that	NULL
identification	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
and	NULL
its	NULL
function	NULL
in	NULL
lymphocytes	NULL
will	NULL
provide	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
role	NULL
of	NULL
vitamin	NULL
D	NULL
in	NULL
immunoregulation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
8351	NULL
We	NULL
thank	NULL
J.	NULL
W.	NULL
Pike	NULL
for	NULL
the	NULL
generous	NULL
provision	NULL
of	NULL
critical	NULL
materials	NULL
for	NULL
this	NULL
study	NULL
and	NULL
for	NULL
discussion	NULL
of	NULL
the	NULL
data	NULL
,	NULL
Lidia	NULL
Maianu	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
Mrs.	NULL
Denise	NULL
Bardonaro	NULL
for	NULL
preparing	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grants	NULL
AI21761	NULL
and	NULL
DK38765	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
by	NULL
the	NULL
Department	NULL
of	NULL
Veteran	NULL
Affairs	NULL
.	NULL

1	NULL
.	NULL

Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Hustmyer	NULL
,	NULL
F.	NULL
G.	NULL
&	NULL
Yu	NULL
,	NULL
X.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Kidney	NULL
Int	NULL
.	NULL

38	NULL
,	NULL
Suppl	NULL
.	NULL

,	NULL
S9-S16	NULL
.	NULL

2	NULL
.	NULL

Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Deftos	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

&	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
Science	NULL
221	NULL
,	NULL
1181-1183	NULL
.	NULL

3	NULL
.	NULL

Bhalla	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Amento	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Clemens	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Holick	NULL
,	NULL
M.	NULL
F.	NULL
&	NULL
Krane	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

57	NULL
,	NULL
1308-1310	NULL
.	NULL

``	NULL
4	NULL
.	NULL

-	NULL
Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
&	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1984	NULL
)	NULL
Science	NULL
224	NULL
,	NULL
1438-1440	NULL
.	NULL

5	NULL
.	NULL

Rigby	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
Stacy	NULL
,	NULL
T.	NULL
&	NULL
Fanger	NULL
,	NULL
M.	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

74	NULL
,	NULL
1451-1455	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Murry	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
&	NULL
Deftos	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

63	NULL
,	NULL
394-400	NULL
.	NULL

7	NULL
.	NULL

Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Watry	NULL
,	NULL
D.	NULL
,	NULL
Escobar	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Dinarello	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Hustmyer	NULL
,	NULL
F.	NULL
G.	NULL
&	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

69	NULL
,	NULL
127-133	NULL
.	NULL

8	NULL
.	NULL

Reichel	NULL
,	NULL
H.	NULL
,	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Tobler	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Norman	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
3385-3389	NULL
.	NULL

9	NULL
.	NULL

Tobler	NULL
,	NULL
A.	NULL
,	NULL
Gasson	NULL
,	NULL
J.	NULL
,	NULL
Reichel	NULL
,	NULL
H.	NULL
&	NULL
Norman	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

79	NULL
,	NULL
1700-1705	NULL
.	NULL

10	NULL
.	NULL

Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Deftos	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

&	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

136	NULL
,	NULL
2734-2740	NULL
.	NULL

11	NULL
.	NULL

Lemire	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Adams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Sakai	NULL
,	NULL
R.	NULL
&	NULL
Jordan	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

74	NULL
,	NULL
657-661	NULL
.	NULL

12	NULL
.	NULL

Pike	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

259	NULL
,	NULL
1167-1173	NULL
.	NULL

13	NULL
.	NULL

Peterson	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1977	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

83	NULL
,	NULL
346-356	NULL
.	NULL

14	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
227	NULL
,	NULL
680-685	NULL
.	NULL

15	NULL
.	NULL

Merke	NULL
,	NULL
J.	NULL
,	NULL
Nawret	NULL
,	NULL
M.	NULL
,	NULL
Hiigel	NULL
,	NULL
U.	NULL
,	NULL
Szado	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Ritz	NULL
,	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Calcif	NULL
.	NULL

Tissue	NULL
Int	NULL
.	NULL

45	NULL
,	NULL
255-256	NULL
.	NULL

16	NULL
.	NULL

Mahonen	NULL
,	NULL
A.	NULL
,	NULL
Pirskanen	NULL
,	NULL
A.	NULL
,	NULL
Kein	NULL
@	NULL
nen	NULL
,	NULL
R.	NULL
&	NULL
Maenpai	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Biochemica	NULL
et	NULL
Biophysica	NULL
Acta	NULL
1048	NULL
,	NULL
30-37	NULL
.	NULL

17	NULL
.	NULL

Strom	NULL
,	NULL
M.	NULL
,	NULL
Sandgren	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Brown	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

&	NULL
Deluca	NULL
,	NULL
H.	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
9770-9773	NULL
.	NULL

18	NULL
.	NULL

Pike	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Kesterson	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Scott	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Kerner	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Mcdonnell	NULL
,	NULL
D.	NULL
P.	NULL
&	NULL
O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
in	NULL
Vitamin	NULL
D	NULL
:	NULL
Molecular	NULL
,	NULL
Cellular	NULL
,	NULL
and	NULL
Clinical	NULL
Endocrinology	NULL
,	NULL
eds	NULL
.	NULL

Norman	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Schaefer	NULL
,	NULL
K.	NULL
,	NULL
Grigoleit	NULL
,	NULL
H.	NULL
G.	NULL
&	NULL
Herrath	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
Walter	NULL
de	NULL
Gruyter	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

215-224	NULL
.	NULL

19	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
841-843	NULL
.	NULL

20	NULL
.	NULL

Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
&	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

68	NULL
,	NULL
774-779	NULL
.	NULL

21	NULL
.	NULL

Yu	NULL
,	NULL
X.	NULL
P.	NULL
,	NULL
Mocharla	NULL
,	NULL
H.	NULL
,	NULL
Hustmyer	NULL
,	NULL
F.	NULL
G.	NULL
&	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
7588-7595	NULL
.	NULL

22	NULL
.	NULL

Kahan	NULL
,	NULL
B.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

321	NULL
,	NULL
1725-1738	NULL
.	NULL

